Catalyst Capital Advisors LLC Eli Lilly & CO Transaction History

Catalyst Capital Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$130.46 - $172.63 $5.19 Million - $6.87 Million	-39,800 Closed	0 $0
Q3 2020 Nov 05, 2020	SELL	$146.22 - $169.13 $336,306 - $388,999	-2,300 Reduced 5.46%	39,800 $5.89 Million
Q2 2020 Aug 10, 2020	SELL	$136.42 - $164.18 $532,038 - $640,302	-3,900 Reduced 8.48%	42,100 $6.91 Million
Q1 2020 May 12, 2020	BUY	$119.05 - $147.35 $5.48 Million - $6.78 Million	46,000 New	46,000 $6.38 Million
Q2 2019 Aug 08, 2019	SELL	$110.79 - $129.32 $41,989 - $49,012	-379 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$111.31 - $131.02 $4,452 - $5,240	40 Added 11.8%	379 $49,000
Q4 2018 Feb 07, 2019	BUY	$105.9 - $118.64 $35,900 - $40,218	339 New	339 $39,000

4,010

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Catalyst Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Catalyst Capital Advisors LLC with notifications on news.